A61K - Cooperative Patent Classification
A61K - Cooperative Patent Classification
A61K - Cooperative Patent Classification
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CPC - <strong>A61K</strong> - 2013.07 - page 43<br />
<strong>A61K</strong> 38/1767 . . . { from invertebrates }<br />
<strong>A61K</strong> 38/177 . . . { Receptors; Cell surface antigens; Cell surface determinants }<br />
<strong>A61K</strong> 38/1774 . . . . { Immunoglobulin superfamily ( e.g. CD2, CD4, CD8, ICAM molecules, B7<br />
molecules, Fc-receptors, MHC-molecules ) }<br />
<strong>A61K</strong> 38/1777 . . . . { Integrin superfamily }<br />
<strong>A61K</strong> 38/178 . . . . { Lectin superfamily, e.g. selectins }<br />
<strong>A61K</strong> 38/1783 . . . . { Nuclear receptors, e.g. retinoic acid receptor (RAR), RXR, nuclear orphan<br />
receptors }<br />
<strong>A61K</strong> 38/1787 . . . . { for neuromediators, e.g. serotonin receptor, dopamine receptor }<br />
<strong>A61K</strong> 38/179 . . . . { for growth factors; for growth regulators }<br />
<strong>A61K</strong> 38/1793 . . . . { for cytokines; for lymphokines; for interferons }<br />
<strong>A61K</strong> 38/1796 . . . . { for hormones ( for neuromediators <strong>A61K</strong> 38/1787 ) }<br />
<strong>A61K</strong> 38/18 . . . Growth factors ; Growth regulators<br />
<strong>A61K</strong> 38/1808 . . . . { Epidermal growth factor (EGF) urogastrone }<br />
<strong>A61K</strong> 38/1816 . . . . { Erythropoietin (EPO) }<br />
<strong>A61K</strong> 38/1825 . . . . { Fibroblast growth factor (FGF) }<br />
<strong>A61K</strong> 38/1833 . . . . { Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II }<br />
<strong>A61K</strong> 38/1841 . . . . { Transforming growth factor (TGF) }<br />
<strong>A61K</strong> 38/185 . . . . { Nerve growth factor (NGF); Brain derived neurotrophic factor (BDNF);<br />
Ciliary neurotrophic factor (CNTF); Glial derived neurotrophic factor (GDNF);<br />
Neurotrophins, e.g. NT-3 }<br />
<strong>A61K</strong> 38/1858 . . . . { Platelet-derived growth factor (PDGF) }<br />
<strong>A61K</strong> 38/1866 . . . . . { Vascular endothelial growth factor (VEGF) }<br />
<strong>A61K</strong> 38/1875 . . . . { Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing<br />
factor }<br />
<strong>A61K</strong> 38/1883 . . . . { Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA,<br />
neu differentiation factor }<br />
<strong>A61K</strong> 38/1891 . . . . [Angiogenesic factors ; Angiogenin]<br />
<strong>A61K</strong> 38/19 . . . Cytokines ; Lymphokines ; Interferons<br />
<strong>A61K</strong> 38/191 . . . . { Tumor necrosis factors [TNF } , e.g. lymphotoxin [LT] i.e. TNF-beta]<br />
<strong>A61K</strong> 38/193 . . . . { Colony stimulating factors [CSF } ]<br />
<strong>A61K</strong> 38/195 . . . . { Chemokines, e.g. RANTES }<br />
<strong>A61K</strong> 38/196 . . . . { Thrombopoietin }<br />
<strong>A61K</strong> 38/20 . . . . Interleukins [IL]<br />
<strong>A61K</strong> 38/2006 . . . . . { IL-1 }<br />
<strong>A61K</strong> 38/2013 . . . . . { IL-2 }<br />
<strong>A61K</strong> 38/202 . . . . . { IL-3 }<br />
<strong>A61K</strong> 38/2026 . . . . . { IL-4 }<br />
<strong>A61K</strong> 38/2033 . . . . . { IL-5 }<br />
<strong>A61K</strong> 38/204 . . . . . { IL-6 }<br />
<strong>A61K</strong> 38/2046 . . . . . { IL-7 }<br />
<strong>A61K</strong> 38/2053 . . . . . { IL-8 }<br />
<strong>A61K</strong> 38/206 . . . . . { IL-9 }<br />
<strong>A61K</strong> 38/2066 . . . . . { IL-10 }